Prosecution Insights
Last updated: May 29, 2026

Rhode Island Hospital

7 pending office actions • 6 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days

Portfolio Summary

7
Total Pending OAs
4
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
4
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (4)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
5
Medium (71%)
0
Easy (0%)
2
Unknown (29%)

Rejection Statute Mix

BucketCases
§103 only5 (71%)
No statute on record2 (29%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
57% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
3
Mechanical / Eng
43% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

70 h
Manual time on pending OAs
14 h
Time saved (low, 20%)
24 h
Time saved (mid, 35%)
0.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SHIBUYA, MARK LANCE 1 32.3% +24.9%
MAYNARD, JOHNATHAN A 1 39.9% +7.2%
SCHUBERG, LAURA J 1 23.7% +36.7%
KIM, EUN HWA 1 71.5% +38.9%
BLUMEL, BENJAMIN P 1 70.7% +30.6%
JAFFRI, ZEHRA 1 62.7% +47.0%
BUCKMASTER, MARLENE VRENI 1 25.9% +74.7%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17974944 Biomaterial for Articular Cartilage Maintenance and Treatment of Arthritis SCHUBERG, LAURA J 38d overdue
16976277 EXOSOME TARGETING OF CD4+ EXPRESSING CELLS BUCKMASTER, MARLENE VRENI 12d

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
17570173 SURGICAL DRAIN REMOVAL DEVICE AND METHODS FOR USING SAME JAFFRI, ZEHRA 89d overdue
17974944 Biomaterial for Articular Cartilage Maintenance and Treatment of Arthritis SCHUBERG, LAURA J 38d overdue
16976277 EXOSOME TARGETING OF CD4+ EXPRESSING CELLS BUCKMASTER, MARLENE VRENI 12d
18276593 RECONSTITUTION OF EXTRACELLULAR MATRIXES FOR MUSCULOSKELETAL JOINT TISSUE REPAIR USING BIOMIMETIC BIOLOGIC AND SYNTHETIC FACTORS SHIBUYA, MARK LANCE 29d
17997329 SHAPE-MEMORY ALLOY AND POLYMER ELECTRODE ARRAY FOR MINIMALLY-INVASIVE SPINAL CORD AND BRAIN STIMULATION AND RECORDING KIM, EUN HWA 30d
17723271 RNA SEQUENCING TO DIAGNOSE SEPSIS AND OTHER DISEASES AND CONDITIONS BLUMEL, BENJAMIN P 35d

Top Art Units

Art UnitApps
1631 2
3798 1
3794 1
1671 1
3771 1
1672 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18276593 RECONSTITUTION OF EXTRACELLULAR MATRIXES FOR MUSCULOSKELETAL JOINT TISSUE REPAIR USING BIOMIMETIC BIOLOGIC AND SYNTHETIC FACTORS SHIBUYA, MARK LANCE 1631 §103 Non-Final OA 29d Pending Aug 09, 2023
18274279 IMAGE-BASED APPROACH TO EVALUATE CONNECTIVE TISSUE STRUCTURE, REMODELING, AND RISK OF INJURY MAYNARD, JOHNATHAN A 3798 §103 Non-Final OA 14d Pending Jul 26, 2023
17974944 Biomaterial for Articular Cartilage Maintenance and Treatment of Arthritis SCHUBERG, LAURA J 1631 Other Final Rejection 38d overdue Pending Oct 27, 2022
17997329 SHAPE-MEMORY ALLOY AND POLYMER ELECTRODE ARRAY FOR MINIMALLY-INVASIVE SPINAL CORD AND BRAIN STIMULATION AND RECORDING KIM, EUN HWA 3794 §103 Non-Final OA 30d Pending Oct 27, 2022
17723271 RNA SEQUENCING TO DIAGNOSE SEPSIS AND OTHER DISEASES AND CONDITIONS BLUMEL, BENJAMIN P 1671 Other Non-Final OA 35d Pending Apr 18, 2022
17570173 SURGICAL DRAIN REMOVAL DEVICE AND METHODS FOR USING SAME JAFFRI, ZEHRA 3771 §103 Final Rejection 89d overdue Pending Jan 06, 2022
16976277 EXOSOME TARGETING OF CD4+ EXPRESSING CELLS BUCKMASTER, MARLENE VRENI 1672 §103 Final Rejection 12d Pending Aug 27, 2020

Managing Rhode Island Hospital's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month